Evotec and HZI join forces in antibiotics discovery
Under the collaboration, the partners will initially focus on optimisation of cystobactamids, a family of natural broad-spectrum myvobacterial...
Preventing virus infections in newborns
Despite existing antivirals, systemic HSV can lead to permanent central nervous system damage such as encephalitis or even death. In Science...
Reprogrammed pancreatic cells cure type I diabetes
Typically, only pancreatic beta, which lack in people with type I diabetes, cells can produce insulin. Pedro Herrera and colleagues investigated...
EMA recommends bluebird's β-thalassemia gene therapy
Patients suffering from beta-thalassaemia cannot produce enough beta-globin, a key component of haemoglobin, the protein that carries the oxygen in...
US patent office grants Charpentier CRISPR patent
ERS Genomics Ltd, which was formed to provide broad access to the CRISPR/Cas9 intellectual property co-owned by Dr. Emmanuelle Charpentier, announced...
AMR network CARB-X expands reach
Launched in the US by BARDA in 2016, CARB-X has a budget of US$450m from 2017 till 2021 for antibacterial R&D, particularly for investments...
Pfizer buys stake in liver gene therapy player Vivet
In the course of its current gene therapy expansion, Pfizer acquired a 15% stake in the Paris-based company that is expected to start Phase I/II...